CorConsult Rx - Here is a summary of CHADS VASc score to evaluate a patient's risk of forming an embolism (leading to a stroke) secondary to their atrial fibrillation. If you answer
![CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome | Heart CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome | Heart](https://heart.bmj.com/content/heartjnl/99/12/843/F3.large.jpg?width=800&height=600&carousel=1)
CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome | Heart
![Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914919306034-gr1.jpg)
Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - ScienceDirect
![Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-021-02384-0/MediaObjects/12882_2021_2384_Fig1_HTML.png)
Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation | BMC Nephrology | Full Text
![CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country](https://ctlin.blog/wp-content/uploads/2019/01/cha2ds2vaschasbled-e1547658221355.png)
CHA2DS2-VASc and HAS-BLED integrated into EHR. Wow. Humility thy name is… – The Undiscovered Country
![Frontiers | Correlation Between CHA2DS2-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study Frontiers | Correlation Between CHA2DS2-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study](https://www.frontiersin.org/files/Articles/653405/fcvm-08-653405-HTML-r1/image_m/fcvm-08-653405-g001.jpg)
Frontiers | Correlation Between CHA2DS2-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study
![Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key](https://thoracickey.com/wp-content/uploads/2016/11/gr1-476.jpg)
Stroke Risk Factors Beyond the CHA 2 DS 2 -VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? | Thoracic Key
![CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download](https://images.slideplayer.com/30/9547440/slides/slide_2.jpg)
CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease. - ppt download
![Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia Al-Turaiki AM, Al-Ammari MA, Al-Harbi SA, Khalidi NS, Alkatheri AM, Aldebasi TM, AbuRuz SM, Albekairy Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia Al-Turaiki AM, Al-Ammari MA, Al-Harbi SA, Khalidi NS, Alkatheri AM, Aldebasi TM, AbuRuz SM, Albekairy](https://www.thoracicmedicine.org/articles/2016/11/2/images/AnnThoracMed_2016_11_2_146_180026_t3.jpg)
Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia Al-Turaiki AM, Al-Ammari MA, Al-Harbi SA, Khalidi NS, Alkatheri AM, Aldebasi TM, AbuRuz SM, Albekairy
![Salim R. Rezaie, MD on Twitter: "CHA2DS2-VaSc more clearly defines anticoag recs vs CHADS2 http://t.co/F3h12hYz9g #FOAMed #FOAMcc #MedEd #ABIM http://t.co/hRIvAo2R1w" / Twitter Salim R. Rezaie, MD on Twitter: "CHA2DS2-VaSc more clearly defines anticoag recs vs CHADS2 http://t.co/F3h12hYz9g #FOAMed #FOAMcc #MedEd #ABIM http://t.co/hRIvAo2R1w" / Twitter](https://pbs.twimg.com/media/BcNYC_6CAAE8aJv.png:large)